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Abstract: Many cell functions in all living organisms rely on protein-based molecular 
recognition involving disorder-to-order transitions upon binding by molecular recognition 
features (MoRFs). A well accepted computational tool for identifying likely protein-protein 
interactions is sequence alignment. In this paper, we propose the combination of sequence 
alignment and disorder prediction as a tool to improve the confidence of identifying  
MoRF-based protein-protein interactions. The method of reverse sequence alignment is 
also rationalized here as a novel approach for finding additional interaction regions, 
leading to the concept of a retro-MoRF, which has the reversed sequence of an identified 
MoRF. The set of retro-MoRF binding partners likely overlap the partner-sets of the 
originally identified MoRFs. The high abundance of MoRF-containing intrinsically 
disordered proteins in nature suggests the possibility that the number of retro-MoRFs could 
likewise be very high. This hypothesis provides new grounds for exploring the mysteries of 
protein-protein interaction networks at the genome level. 
Keywords: reverse; retro; invert; alignment; intrinsic disorder; PONDR-RIBS 
 
OPEN ACCESS
Int. J. Mol. Sci. 2010, 11             
 
 
3726
1. Introduction 
All the challenges in biological research may come down to the molecular level and be conquered 
by various physical and chemical interactions among various bio-molecules, such as proteins, DNA, 
and RNA. The peculiarities of the interaction patterns between these molecules can be represented as 
various interaction networks. The sequential and spatial effects of these interaction networks control 
the origin, development, and evolution of all living organisms. Therefore, identifying possible 
interactions among various bio-molecules is of great importance for current biological science.  
However, identifying inter-molecular interactions, especially in vivo, is not a trivial task. 
Traditional experimental methods are both time- and cost-consuming. Advanced experimental 
methods, such as yeast 2 hybrid, although fast and efficient, have significant false positive and false 
negative rates. In spite of these experimental difficulties, developments in bioinformatics have made a 
great contribution in this area. Techniques based on sequence alignment become the most basic but 
very powerful tools for identifying structures, functions, and mutual interactions among bio-molecules. 
The underlying principle supporting the application of sequence alignment for studies of protein 
structure and function is the well-accepted sequence-structure-function paradigm: Sequence 
determines the structure; Structure determines the function. Here, for the simplicity of description, 
function can be interpreted as the ability of a bio-molecule (protein) to interact with another molecule. 
Apparently, this ability is due to the local structure determined by the spatial arrangement of amino 
acids, which is encoded in protein’s amino acid sequence. If two proteins have very similar sequences, 
their structures are very likely to be highly similar, and, therefore, they may have a very similar 
interaction mode with the third molecule. This is the underlying basis for the sequence alignment. 
Although the underlying principles of sequence alignment have integrated many atomic details 
implicitly, the application of sequence alignment raised itself to the phenomenon level. In fact, only 
the sequential order of the symbols of amino acid residues is required for the alignment: If the 
sequential orders of amino acids in two proteins are similar to each other, their structures and functions 
are likely to be similar to each other as well. This logic can also be applied to protein domains or 
segments: if two segments have similar sequential order of amino acids, they may form similar local 
3D structures and perform similar functions. Many conserved motifs and active sites are identified 
through this process. Although for highly conserved segments, the structural and functional prediction 
from sequence alignment is highly convincing, there are a lot of uncertainties for moderately similar 
segments. Furthermore, there is another intriguing question: if the segment A is reversely identical to 
the segment B, are they similar in structure and function? This is a very important question. In fact, if 
the answer to this question is positive or partially positive under some conditions, the interaction 
patterns ascribed to bio-molecular pathways and networks could be far more complicated.  
Several pioneer studies have been performed to address the issue of proteins with reversed 
sequences (retro-proteins). As early as 1992, Schoniger and Waterman introduced inversion (reversed 
complements) into sequence alignment [1]. However, it was not clear whether the reversed sequences 
have the same structure and function as the original, normal-order, sequences. Later, studies of 
different proteins and models produced contradictory results. For example, computational simulations 
based on the coarse grained model of the domain B of staphylococcal protein A indicated that the 
retro-sequence would likely have a structure similar to that of the original sequence [2]. However, 
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according to the full-atom simulations and experiments, this retro-protein was shown to be essentially 
unfolded [3]. In addition, retro-proteins produced from sequences of SH3 domain and B1 domain of 
Streptococcal protein G were also shown to be unfolded by both full-atom simulation and 
experiments [3]. Several reversed polypeptides possessed conformations totally different from their 
conformations of original sequences [4,5]. Apparently, the results of the coarse grained modeling of 
the retro-proteins were different from all-atom models. Very likely, the difference comes from the 
differences of the local, detailed structures of amino acids; i.e., dihedral angles and side chain 
orientations, which are omitted in the coarse grained model. In addition to these individual examples, a 
statistical study revealed that retro-sequences are unlikely to have fold similar to the original 
sequences [6,7]. In contrast to these various studies, there are still other experimental examples 
showing that although retro-sequences may have not only a stable 3D structure [8], but may also have 
functions similar to original sequences [9–12].  
All the above mentioned studies were focused on ordered proteins with unique rigid structures. 
These studies clearly showed that the folding of retro-proteins is generally perturbed compared to their 
normal-sequence counterparts and that the presence of reversed segments may dramatically change the 
rigid 3D structure of an ordered protein. However, what happens with respect to reversed sequences of 
intrinsically disordered proteins (IDPs)? IDPs do not have unique 3D structures under physiological 
conditions. Instead, they form an ensemble of flexible conformations. Many crucial biological 
functions are carried out by these dynamic and flexible conformations via structural changes and 
conformational transformations [13–16]. Although the mentioned conformational flexibility makes 
IDPs totally different from structured proteins, no study on reversed alignments has been reported for 
these proteins that lack stable structure.  
Since IDPs have much more structural flexibility, the underlying assumptions for sequence 
alignment of IDPs may be very different from those proposed for aligning the structured proteins. In 
fact, for structured proteins, when the sequence identity is over 20–30%, the corresponding structural 
similarity is potentially very high (in terms of RMSD, the difference between two structures of this 
sequence identity is often less than 2 Å)  [17]. How similar are structures and functions of two 
disordered proteins when their sequence similarity is only 20–30%? How different are structures and 
functions of IDPs, with normal order and reversed sequences? In other words, how are the structures 
and functions of IDPs affected by inversion of their amino acid sequences? These questions can hardly 
be neglected due to the high abundance of IDPs in nature. Typically, 7–30% prokaryotic proteins 
contain long disordered regions of more than 30 consecutive residues, whereas in eukaryotes the 
amount of such proteins reaches 45–50% [18–22]. Even in the PDB database, which is highly biased 
towards structured proteins, ~70% of proteins have regions of missing electron density, i.e., disordered 
regions [23]. Of these, over 10% have long segments of missing electron density consisting of at least 
30 amino acids [24]. As far as the protein functions are concerned, as emphasized by previous studies, 
238 out of 710 Swiss-Prot functional keywords were strongly positively correlated with intrinsic 
disorder, while 302 other functional key words were strongly negatively associated with intrinsic 
disorder [25].  
In this paper, we describe an integrated analysis of the relation between the reversed sequence, 
sequence alignment, and intrinsic disorder. Furthermore, by combining these three features, we 
developed a novel protocol for identification of potential protein-protein interaction sites, herein called 
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retro-MoRFs, which are reversed-sequence molecular recognition features. Just as commonly observed 
for normal-sequence MoRFs, retro-MoRFs are short segments that are expected to have a high 
propensity for folding-upon-binding and that are located within regions of disorder.  
Figure 1. Disorder and MoRF prediction for (a) RNase E, (b) p53, and (c) SRC-3. The 
thin solid lines are prediction of PONDR-VLXT, dotted lines are prediction from PONDR-
FIT, and horizontal bold lines are the MoRF regions identified by MoRF-II predictor. In 
subset (a), N and C1-C4 correspond to one N-terminal dip and four C-terminal dips of 
RNase E. In subset (b), N, C1, and C2 stand for N-terminal dip and two C-terminal dips for 
p53. In (c), there are one N-terminal dip N, two middle-region dips M1 and M2, and two  
C-terminal dips C1 and C2. 
2. Results and Discussion 
2.1. Functional Roles of MoRF Regions in Three Proteins 
Figure 1 shows disorder prediction and its relation to MoRFs [22,26] for three illustrative proteins:  
(a) RNase E, (b) p53, and (c) SRC-3. PONDR-VLXT and PONDR-FIT were used to make the disorder 
predictions. The former predictor is the more sensitive to the local amino acid composition, while the 
latter is one of the most accurate disorder predictors. As shown by Figure 1(a)–(c), although the 
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general trends are similar, PONDR-VLXT has more intense fluctuation of disordered scores, whereas  
PONDR-FIT shows smaller fluctuations and more gradual variation overall. The dips reflected by the 
disorder score fluctuations may correspond to MoRF regions. The protein segments corresponding to 
these dips have much higher content of hydrophobic residues than their flanking regions. Since 
increased hydrophobicity favors structure over disorder in PONDR-VLXT, such segments are 
predicted to be locally structured by this predictor, while the neighboring regions are more strongly 
predicted to be disordered. From a biological viewpoint, due to high local content of hydrophobic 
residues, the protein segments corresponding to these dips may have crucial roles in molecular 
recognition and signaling. However, not all of the dips can be identified as -MoRFs. In fact, the 
application of the -MoRF identifier [22,26] reveal only four -MoRFs in RNase E (Figure 1(a)), 
three -MoRFs in p53 (Figure 1(b)), and sixteen -MoRFs in SRC-3 (Figure 1(c)).  
All the -MoRFs in Figure 1(a) and (b) were selected for further study. But only four out of sixteen 
-MoRFs from Figure 1(c) were chosen. In addition, the segment “C3” in Figure 1(a) and the segment 
“N” in Figure 1(c), which showed particularly sharp dips, were also selected for further analysis. All 
these regions will be called MoRFs or MoRF regions in the following discussions.  
The fragment N of RNase E is located in a structured domain. It has a -strand at the N-terminus 
followed by a coil at the C-terminus. A short part of the C-terminal coil has missing electron density in 
crystal structure [27], but can also form both -helix [28] and -strand [27]. Three other segments of 
interest are located in the intrinsically disordered C-terminal domain of the protein. The RNase E 
efragment C1 was proposed to be involved in protein self-association [29]. The segment C2 was 
suggested to interact with structured RNAs and contribute to oligomerization [29]. C3 and C4 regions 
were observed to bind to enolase and PolyNucleotide Phosphorylase (PNPase), respectively [29].  
The MoRF regions of p53 can interact with many other proteins [30]. The following provides a 
small sampling of a much larger set of experimentally verified. The fragment N of p53 binds to 
MDM2 [31] and PH-domain of Tfb1 subunit [32]. The C1 segment of p53 can bind to tetrahymena 
GCN5 [33] and is also responsible for the formation of the p53 tetramer [34]. Finally, the C2 region 
can interact with four unrelated proteins: cyclin A [35], sirtuin [36], bromodomain of CREB Binding 
Protein (CBP) [37], and S100 [38], and, for these particular examples, there are 3-D structures of 
the various complexes between the p53 fragment and these four different partners [35–38]. 
In SRC-3, the N segment is located in the basic Helix-Loop-Helix motif (bHLH). The bHLH motif 
is well-conserved among other members of the SRC family. Although there are no structural 
determinations of the of SRC-3 bHLH motif bound with other molecules, this conserved motif of  
SRC-2 was shown to interact with myogenic factors, such as myogenin and MEF-2C [39], as well as 
with the Transcriptional Enhancer Factor 4 (TEF-4) [40]. The segments M1 and M2 are so called 
LxxLL motifs, where L is leucine and x is any amino acid. If the residues designated by x are polar 
and if the residues before and after this motif are also polar, then this motif would form one turn of an 
amphiphatic -helix [41,42] with conserved leucines forming a closely-packed triangle on one face of 
the helix. This hydrophobic patch can interact with various nuclear receptors [43–46], and are 
characterized by an adjustable binding affinity [47]. The C1 segment is located in the intrinsic 
transcriptional Activation Domain 1(AD1) and also contains a LxxLL motif. This segment is 
responsible for the SRC-3 interaction with general transcriptional co-integrator CBP/p300 [46]. The 
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C2 segment is in the AD2 domain which interacts with Co-Activator-associated aRginine  
N-Methyltransferase 1 (CARM1) and Protein aRginine N-MethylTransferase 1 (PRMT1) [48]. 
Therefore, all the fragments of the three proteins discussed herein are biologically important and are 
involved in a wide range of specific interactions. 
2.2. Alignment of MoRFs by Normal Sequential Order 
Table 1 lists proteins containing the segments that have similar sequences (with E-value less than 
0.0001) to MoRF segments of RNase E, p53, and SRC-3. Apparently, none of the PDB sequences 
contain segments similar to these MoRF regions under current selection criteria. However, a number of 
sequences in SwissProt have segments similar to these MoRF regions. In fact, in SwissProt, there are 
16 annotated unique proteins and 2 putative proteins. Out of these 16 proteins, 10 are ended with  
“-ase”, 4 are related to regulation, 1 is related to cell shape, and another one is a chaperone. More 
interestingly, both hydroxyethylthiazole kinase and rRNA pseudouridylate synthase C have two 
segments similar to a MoRF of RNase E. 
Table 1. MoRFs of three proteins and their alignment matches in PDB and SwissProt. 
Protein MoRF 
Proteins in PDB 
containing similar 
MoRF (a) 
Proteins in SwissProt containing similar MoRF (a) 
SwissPr
ot id 
Species Name 
Within 
IDR 
RNase 
E 
N --- 
Q9R5Y8 E. Coli Cell shape determining protein Yes 
A5UA75 Haemophilus influenzae Hydroxyethylthiazole kinase Yes 
A4NVQ
3 
Haemophilus influenzae rRNA pseudouridylate synthase C Yes 
Q65S31 
Mannheimia 
succiniciproducens 
CafA protein Yes 
C1 --- ---  --- --- 
C2 --- 
B0U5Z2 Xylella fastidiosa Glutamyl-tRNA reductase Yes 
Q65I31 Bacillus licheniformis Anthranilate synthaseTrpE Yes 
C3 --- 
A5UA75 Haemophilus influenzae Hydroxyethylthiazole kinase Yes 
A4NVQ
3 
Haemophilus influenzae rRNA pseudouridylate synthase C No 
Q65S31 
Mannheimia 
succiniciproducens 
CafA protein No 
C4 --- ---  --- --- 
p53 
N 
--- 
A0M1H
7 
Gramella forsetii Carbohydrate kinase Yes 
--- B9RU24 Ricinus communis 
Mitochondrial respiratory chain 
complexes assembly protein, 
putative 
 
C1 --- C6Y295 Pedobacter heparinus DNA polymerase III, α subunit No/Yes 
C2 --- ---  --- --- 
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Table 1. Cont. 
Protein MoRF 
Proteins in PDB 
containing similar 
MoRF (a) 
Proteins in SwissProt containing similar MoRF (a) 
SwissProt 
id 
Species Name 
Within 
IDR 
SRC-3 
N --- ---  --- --- 
M1 --- 
Q6NSP2 Zebrafish 
Rho/rac guanine nucleotide exchange 
factor (GEF) 
Yes 
B7JAA3 
Acidithiobacillus 
ferrooxidans 
Nif-specific regulatory protein Yes 
B5ER80 
Acidithiobacillus 
ferrooxidans 
Transcriptional regulator, NifA, Fis 
Family 
Yes 
A6VPZ1 
Actinobacillus 
succinogenes 
Sulfite reductase [NADPH] hemoprotein 
beta-component 
No 
Q01FQ6 
Ostreococcus 
tauri 
CLP protease regulatory subunit CLPX 
(ISS) 
Yes 
A4RRW1 
Ostreococcus 
lucimarinus 
Mitochondrial ClpX chaperone Yes 
M2 --- 
Q6N6F5 
Rhodopseudomo
nas palustris 
ATP-dependent DNA helicase Yes 
C1AT82 
Rhodococcus 
opacus 
Hypothetical membrane protein No 
B3QIU1 
Rhodopseudomo
nas palustris 
DEAD/DEAH box helicase domain 
protein 
Yes 
C1 --- ---  --- --- 
C2 --- ---  --- --- 
(a) Only proteins different from the original protein and its family are listed. 
According to our assumption, if these similar segments are flanked by disordered regions, they may 
have similar binding functions as the original MoRF segments. Hence, PONDR-FIT was applied to 
predict the disordered status of all these SwissProt sequences.  
For the purpose of comparing various sequences containing the same MoRF segments, their 
disorder predictions were presented in the same type of plot (Figure 2). Since seven of the MoRFs 
listed in Table 1 have sequences similar to unrelated proteins in SwissProt, there are 7 plots in Figure 2 
with each plot corresponding to a MoRF segment in Table 1. The inset of each plot is the BLASTP 
alignment of sequences at the MoRF region. Although there were insertions in the original alignments, 
these insertions were deleted for the simplicity of matching the curve of disorder prediction. 
The MoRF region N of RNase E is highly conserved among five different proteins, where CafA 
(Q65S31) is also a member of RNase family. As indicated by the prediction in Figure 2(a), this 
segment in all five molecules is flanked by disordered regions. Although the specific role of MoRF N 
in RNase E is not clear, the entire N-terminal region of RNase E forms a structured catalytic domain. 
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Figure 2. Disorder prediction and sequence alignment for proteins shown in Table 1, 
which are alignment matches of all the MoRF regions of three proteins in our study. The 
alignment was cut off at E-value of 0.001. The disorder prediction was implemented by 
PONDR®VL-XT. The partially sequence alignment is shown as the inset. The insertions 
in the original alignment were deleted for matching the curve of disorder prediction. The 
curves of disorder score were shifted to overlap the aligned segments. The N, C2, and C3 
MoRF regions of RNase E are shown in (a), (b), and (c), respectively. (d) and (e) are the N 
and C1 MoRF regions of P53. (f) and (g) are the M1 and M2 MoRF regions of SRC-3. 
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Figure 2. Cont. 
 
Due to this high sequence conservation and matching disordered profile, the segments in four 
proteins may have functions similar to those of the RNase E MoRF region N. Two different proteins in 
SwissProt contain segments similar to C2 region of RNase E. However, the peculiarities of order-
disorder predictions for these three molecules are quite different. As shown in Figure 2(b), C2 region 
of RNase E is flanked by disordered regions. The same segment in B0U5Z2 and Q65I31 shows are 
located in short disordered regions which has only about 25 residues in B0U5Z2 and about 40 residues 
in Q65I31. Hence, the RNaseE-C2-like segments in both B0U5Z2 and Q65I31 are likely to serve as 
disordered linkers rather than binding regions. 
The C3 region of RNase E was observed to bind to enolase [29]. In STRING 8.2, RNase E was also 
shown to interact with enolase. As shown by Figure 2(c), Q65S31, A5UA75, and A4NVQ3 all have 
RNaseE-C3-like segment within a disordered region. The alignment and disorder prediction indicate 
that these three proteins may also interact with enolase. Actually, as indicated by STRING 8.2, 
Q65S31 interacts with enolase with high confidence score (~0.999); A5UA75 can also interact with 
enolase with a score of 0.829. Although the interaction network of A4NVQ3 is missing in STRING 
8.2, due to the high sequence identity between A4NVQ3 and Q65S31, it is very likely that A4NVQ3 
will also interact with enolase. 
The p53-N-like segment was found in two sequences of SwissProt. As illustrated by Figure 2(d), 
this segment in carbohydrate kinase (A0M1H7) is predicted to be structured in the middle of a long 
structured domain. The interaction profiles of p53 and A0M1H7 in STRING 8.2 have no common 
partners. The similar segment in mitochondrial respiratory chain complex assembly protein (B9RU24) 
seems to contain a MoRF located in a middle of a long loop. It is reasonable that this fragment of 
B9RU24 could have the same function as the p53-N segment.  
The p53-C1-like segment has only one similar sequence in SwissProt, DNA polymerase III alpha 
subunit (C6Y295). The disordered pattern of this identified protein near the segment is very different 
from p53. Actually, as indicated by Figure 2(e), this segment is located in a structured region, whereas 
the C1 segment of p53 is within the disordered region. Hence, it is unlikely that they will have the 
same binding partner. 
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The SRC-3-M1 segment is the most commonly matched sequence in SwissProt with six examples, 
as shown in Figure 2(f). Clearly, the matched segments in Q6NSP2, B5ER80, B7JAA3, and A4RRW1 
are predicted to be disordered and are likely to serve as linkers connecting ordered regions. B7JAA3 
and B5ER80 segments actually belong to the same protein found in different strains of 
Acidithiobacillus ferrooxidans. In A6VPZ1, the segment is a part of the structured domain. In 
Q01FQ6, the SRC-3-M1-like segment is located within a disordered region and therefore can 
potentially serve as a binding motif. Therefore, the only possible candidate having binding partner 
potentially similar to that of SRC-3-M1 segment is Q01FQ6.  
The SRC-M2 segment has three matches in SwissProt. In Figure 2(g), the segment in C1AT82 is a 
located within a long region predicted to be structured. On the other hand, the segments in Q6N6F5 
and B3QIU1 both appear to be structure-prone segments flanked by disordered regions. Besides, the 
entire sequences of Q6N6F5 and B3QIU1 are almost identical to each other with only several 
mutations. Thus, these two proteins may also have the same interaction partner as SRC-3. 
2.3. Reversely Identified Potential Binding Sites 
Table 2 shows sequences containing segments similar to reversed MoRF regions with E-value less 
than 0.0001. Again, there are no hits in PDB, but quite a few in SwissProt. There are totally  
20 proteins in Table 2. The comparison of disorder prediction for proteins containing the same 
segments is shown in Figure 3. All the sequences in Figure 3 were also shifted to overlap the similar 
segments. And the original sequences from RNase E, p53, and SRC-3 were inverted to fit the other 
reversely identified sequences. 
The MoRF N segment of RNase E has one reversely aligned match, glycosyl transferase family 2 
(B8EIZ0). Figure 3(a) shows that this segment on B8EIZ0 is predicted to be disordered but it is also a 
connecting segment of two structured regions. Hence, although these two segments highly resemble 
each other and have almost perfect match of their hydrophobic/hydrophilic patterns, their functional 
resemblance on binding, if any, is not clear. 
The rC1 of RNase E also has one alignment hit in SwissProt, a putative uncharacterized protein 
(A0RVW2). This protein has 2429 residues. Disorder prediction in Figure 3(b) shows a promising 
pattern: the RNaseE-rC1-like segment is at the very C-terminal part of A0RVW2 and clearly shows a 
dip within a disordered region. Both segments have the hydrophilic / hydrophobic pattern expected for 
an amphipathic helix [41,42]. It is very likely that this RNaseE-rC1-like segment of A0RVW2 will 
have the similar function as the C1 MoRF region of RNase E. Actually, C1 MoRF region of RNase E 
is responsible for self-association, and RNaseE-rC1-like segment of A0RVW2 is at the very end of  
C-terminal, giving some further confidence on its function in self-association. 
The rC2 fragment of RNase E has five matches in SwissProt. As indicated by Figure 3(c), the  
rC2-like segment of A8IXM6 is located in the N-terminal region and is close to a dip within a long 
disordered region. The similar segment in C0VZ26 is predicted to be highly disordered and is located 
at the very end of the N-terminus of the protein. The rC2-like segments of Q7KA80, and A1ZBW0 are 
also located at the N-terminal parts of the corresponding proteins. However, they are predicted to be 
disordered and contain shallow order dip suggesting that they might be involved in binding. 
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Table 2. Reversed segments of MoRFs of three proteins and their alignment matches in 
PDB and SwissProt. 
Protein MoRF(a) 
Proteins in PDB 
containing 
similar MoRF (b) 
Proteins in SwissProt containing similar MoRF (b) 
SwissProt 
id 
Species Name 
Within 
IDR 
RNase 
E 
rN --- B8EIZ0 
Methylocella 
silvestris 
Glycosyl transferase family 2 Yes 
rC1 --- A0RVW2 
Cenarchaeum 
symbiosum 
Putative uncharacterized protein Yes 
rC2 --- 
A8IXM6 
Chlamydomonas 
reinhardtii 
Dopamine beta-monooxygerase-
like protein 
Yes 
C0VZ26 
Actinomyces 
coleocanis 
30S ribosomal protein S5 Yes 
Q2C7B7 Photobacterium Pseudouridine synthase Yes 
Q7KA80 
Drosophila 
melanogaster 
Heterogeneous nuclear 
ribonucleoprotein 
Yes 
A1ZBW0 
Drosophila 
melanogaster 
Bancal isoform C Yes 
rC3 --- ---  --- --- 
rC4 --- B9LNU7 
Halorubrum 
lacusprofundi 
Manganese containing catelase Yes 
p53 
rN --- ---  --- --- 
rC1 --- 
B8F7I3 
Haemophilus 
parasuis serovar 5 
tRNA modification GTPase TrmE Yes 
Q0QE22 
Haemophilus 
parasuis 
ThdF Yes 
A8FF31 Bacillus pumilus 3-dehydroquinate dehydratase No 
rC2 --- ---  --- --- 
SRC-3 
rN --- 
B6R7C1 Pseudovibrio Outer surface protein No 
Q0SCR7 Rhodococcus Aldehyde dehydrogenase Yes 
C1B3Y6 
Rhodococcus 
opacus 
Phenylacetic acid degradation 
protein PaaN 
Yes 
rM1 --- C5PX68 
Sphingobacterium 
spiritivorum 
Conserved hypothetical 
transmembrane protein 
No 
rM2 --- 
Q880S9 
Pseudomonas 
syringae 
AraC-family transcriptional 
regulator 
No 
Q1DCP2 
Myxococcus 
xanthus 
Tetratricopeptide repeat protein No/Yes 
Q8NLQ1 
Corynebacterium 
glutamicum 
UDP-galactopyranose mutase No 
A4CL95 
Robiginitalea 
biformata 
Type III restriction enzyme No 
rC1 --- ---  --- --- 
rC2 --- Q5AHB1 Candida albicans 
Actin cytoskeleton-regulatory 
complex protein PAN1 
Yes 
(a) “r” stands for reversed segment.  
(b)Only proteins other than original proteins and its family are included. 
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The similar segment of Q2C7B7 resides close to the C-terminus of the protein and is also predicted 
to be disordered and contain a shallow order dip. Although there are no obvious conserved 
hydrophobic sites, these proteins do have interesting patterns of positively and negatively charged 
residues. This is clearly an indication of their potential ability to bind to DNA and/or RNA. Actually, 
the C2 region of RNase E is responsible for RNA binding and oligomerization. Therefore, it is quite 
likely that all the five matched proteins will have the same functions.  
The alignment match of rC4 of RNase E in Figure 3(d) shows a similar picture as that for rC1 
region of RNase E. The aligned segment of A0RVW2 is located at the C-terminal part of the molecule 
and shows a dip within the disordered region. This is a sign of a potential binding motif. The sequence 
pattern may also support the formation of helix. Since the original C4 MoRF of RNase E is responsible 
for binding to PNPase, it is very likely that A0RVW2 may also bind to PNPase. 
In p53, only C1 MoRF region has reversely aligned matches in SwissProt. There are totally three 
matches as in Figure 3(e). B8F7I3 and Q0QE22 have p53-rC1-like segment at their C-termini. 
Compared to Q0QE22, B8F7I3 has several mutations. The p53-rC1-like segments of these two 
proteins are predicted to be disordered. Therefore, it is not clear whether these segments could be 
involved in binding. As to A8FF31, although the p53-rC1-like segment is close to the N-terminus, it is 
essentially a part of structured domain. Hence, it is hard to suggest its binding ability.  
Figure 3. Disorder prediction and sequence alignment for proteins in Table 2, which are 
reverse alignment matches of all the MoRF regions of three proteins. The alignment was 
also cut off at E-value of 0.001. Disorder scores were predicted by PONDR®VL-XT. In 
the insets of sequence alignment, the sequential order of original MoRF regions were 
shown in a reversed order, while other alignment hits were shown in normal sequential 
order. The curves of disorder score were also shifted to allowed the overlapped of aligned 
segments. N, C1, C2, and C4 MoRF regions of RNase E were shown in (a)–(d), 
accordingly. C1 MoRF region of P53 was presented in (e). N, M1, M2, and C2 MoRF 
regions of SRC-3 were plotted in (e)–(i), respectively. 
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structural complementation among all other parts of the protein and the partner. Due to this 
requirement of structural complementation, reversing the orientation of the fragment may invalidate 
the binding between the protein and the partner because the structure of the fragment is asymmetric. 
The integrated structure of the reversed fragment and all other parts of the same protein may not match 
to the structure of the partner. That is the reason why reverse alignment is not broadly adopted in the 
research of protein structural biology.  
Theoretically, it was expected that a retro-protein; i.e., a protein obtained as a result of reading the 
sequence backwards, might adapt a topological equivalent of the mirror image of the 3-D structure of 
its parent protein [1,2,49]. However, the lattice model simulations of the retro-sequence of the B 
domain of Staphylococcal protein A revealed that the secondary structure elements in the retro-protein 
did not exactly match their counterparts in the original protein structure [2], and later the full-atom 
simulation analysis showed that this retro-protein was essentially unfolded [3]. Based on the analyses 
of inverse sequence similarity in proteins it has been concluded that the tertiary structures of  
retro-proteins did not imply folds comparable to their parent protein [6]. Furthermore, it was shown 
that the sequence inversion affected the foldability of some model peptides and proteins in such a way 
that retro-proteins were generally no more similar to their parent sequences than any random sequence, 
despite their common hydrophobic/hydrophilic pattern, global amino acid composition and possible 
tertiary contacts [9]. Therefore, it has been concluded that the direction of protein sequence is a critical 
factor for the formation of a unique structure. This directionality explains why the sequences of 
ordered proteins are generally not palindromic [9]. The differences between the parent and retro-
proteins likely originate from the differences in the local, detailed structures of amino acids, their 
dihedral angles, side chain orientations, and packing inside a protein structure.  
In agreement with this hypothesis, careful analysis of biologically active retro-protein, retro human 
metallothionein-2  domain, revealed that despite the significant alterations in the protein structure 
induced by the reversal direction of the domain sequence backbone, this retro-domain retained its 
metal binding ability and foldability mostly due to the fact that reversion of a sequence was not critical 
to the interaction between Cys side chains and metal ions [9]. Another potential exceptions form the 
mentioned spatial restrictions are polyproline II (PPII) helices, which tend to occur on the surface of 
the protein, and PPII-based binding motifs. These structural motifs are left-handed, all-trans extended 
helices with average backbone dihedral angles of (Φ,Ψ) = (−75°, +145°). Each PPII helix has precisely 
three residues per turn, compared with 3.6 residues per turn in an α-helix. This results in a 
considerably extended helical structure, with PPII helices translating 3.12 Å per residue compared to 
1.50 Å per residue in the α-helix. Each turn of a PPII helix spans approximately 9 Å, resulting in 
perfect three-fold rotational symmetry [50,51]. Furthermore, residues in PPII helices are significantly 
more solvent exposed than the average for all residues in ordered proteins, with polar residues in PPII 
helices 60% more solvent exposed and hydrophobic residues 50% more exposed than the average for 
all residues [50]. This high surface exposure of both the hydrophobic and polar side chains of residues 
in PPII conformation provides for an easily accessible hydrophobic or polar interaction surface. As a 
result, proline-rich sequences are very common recognition sites for protein-protein interaction 
modules such as the SH3 domain, the WW domain, and the EVH1 domain [52]. For example, the 
consensus ligand peptides interacting with various SH3-domain-containing proteins in yeast were 
assigned to class I (RXXPXXP) or class II (PXXPXR) motifs [53], which both regarded as a Pro-rich 
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core LPPLP motif, with the position of the R residue (N or C-terminal to the Pro core) dictating 
whether the ligand falls in class I or class II [54]. Furthermore, due to the high symmetry, and due to 
the fact that the PPII helix has three residues per turn, where residues at positions i and i + 3 lie on the 
same edge of the ligand structure, PPII-based binding motifs can be inverted. In fact, class I and class 
II ligands bind to the SH3 domain in reverse orientations relative to each other [55], where a class I 
ligand binds with its N-terminus at the RT loop and a class II ligand with its C-terminus at this site.  
Obviously, the mentioned restrictions in fine structure, dihedral angles, and side chain packing 
details imposed by backbone directionality that prevent normal folding of retro-sequences can be 
avoided if intrinsic disorder is taken into account. Intrinsic flexibility of IDPs and IDRs might allow 
them to gain specific structures needed for successful and specific binding to their partners. Therefore, 
the spatial hindrance of binding between a reversed fragment and a partner can be conquered by the 
flexibility of the flanking regions or the binding region itself. Hence, the combination of reverse 
sequence alignment with disorder analysis might provide very useful information for identifying the 
possible interaction regions.  
Taken fragment F in protein A can bind to partner P and protein B contains a segment rF which has 
a reversed sequence of fragment F, then the question is whether the protein B can interact with partner 
P? To answer this question, the software package, PONDR-RIBS was developed. This new tool 
provides a synthetic analysis of the binding capability of a reversed fragment and the partners. 
PONDR-RIBS aligns sequences by CLUSTALW [56] and predicts intrinsic disorder by  
PONDR-FIT [57]. Here, we restricted the criteria as follows: (1) the sequence identity between 
reversed fragment rF and the original fragment F is higher than 60%; (2) The aligned fragment rF has 
similar hydrophobic/charge pattern as that of fragment F; and (3) The aligned fragment rF is 
disordered or is flanked by disordered regions. If all these conditions are satisfied, then reversed 
fragment rF of protein B might interact with partner P with a high probability. 
Obviously, the principles of PONDR-RIBS may be used not only for the reversed alignment, but 
also for the normal-order alignment. Suppose a segment F binds to partner P and F* is a segment 
sequentially similar to F, the probability of F* binding to P should be much higher if F* is flanked by 
disordered regions or locates in a disordered tail. Hence, by combining the normal-order sequence 
alignment and disorder prediction, the certainty of identifying binding segments can be significantly 
improved. 
In addition, for proteins having interaction profile in STRING 8.2 [58], we will also cross-reference 
the results of this database to validate our assumptions on the interaction between two molecules. 
3.2. Disorder Prediction 
Two disorder predictors were applied in this study. The first predictor is PONDR-VLXT [20], 
which is one of the first disorder predictors. PONDR-VLXT applies various compositional 
probabilities and hydrophobic measures of amino acids as the input features for the prediction. 
Although it is no longer the most accurate predictor, it is very sensitive to the local compositional 
peculiarities of the amino acid sequence. Hence, it is capable of identifying disordered regions 
possessing increased capability to fold upon interaction with binding partners. Based on this property, 
another predictor called Molecular Recognition Feature (MoRF) predictor [22,26] was developed to 
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identify the structure-prone segment in a disordered region. The identified segment is known as MoRF 
region which generally corresponds to the specific dips in the PONDR-VLXT prediction. The second 
predictor applied in this study is PONDR-FIT [57], which is a meta-predictor combining six individual 
predictors, PONDR-VLXT [20], VSL2 [59], VL3 [60], FondIndex [61], IUPred [62], and 
TopIDP [63]. This meta-predictor is a bit more accurate than its individual components and other 
predictors. Because the identification of possible binding regions relies on the recognition of 
disordered regions, PONDR-FIT is a good choice for the disorder prediction.  
3.3. Proteins Studied by PONDR-RIBS 
Proteins interact with their partners in an almost endless variability of binding modes. Among them, 
MoRF is one of the simplest binding motifs which is strongly related to intrinsic disorder [22,26]. 
MoRFs, short protein segments undergoing disorder to order transition upon binding to a partner, play 
important functional roles in protein recognition, signaling, and regulation. Often, MoRFs correspond 
to dips in the PONDR-VLXT plots emphasizing the utility of this computational tool. Although 
PONDR-VLXT is not the most accurate predictor of intrinsic disorder at the amino acid level, it is 
absolutely indispensable for finding the short interspersed disordered/structured regions due to its 
sensitivity to local amino acid composition. These short interspersed disordered/structured regions 
may have many important types of biological functions. MoRFs, being actually one type of the 
interspersed structure-prone motif within disordered regions, are highly abundant in protein sequences. 
In fact, over 40% proteins in eukaryotes genomes are predicted to contain at least one -helical 
MoRF [22,64].  
Due to these considerations, three disordered proteins containing multiple MoRF regions were 
selected for further study, i.e., RiboNuclease E (RNase E) (SwissProt id: P21513), p53 (SwissProt id: 
P04637), and Steroid Receptor Co-activator 3 (SRC-3) (Swissprot id: Q9Y6Q9). RNase E is an 
important enzyme in the pathway of mRNA degradation. p53 plays a number of important roles in cell 
differentiation, development, and genome stability. SRC-3 assists the regulation of gene expression. 
Each of these three proteins binds to many partners through their MoRF regions. By our assumption, a 
query protein containing fragment similar to these MoRFs or their reversed versions may also interact 
with the same partners.  
3.4. Alignment against Various Protein Databases 
PONDR-RIBS provides synthetic comparison between a segment and protein sequences by 
applying multiple sequence alignments and disorder prediction. However, these two steps are 
extremely  
rate-limiting in the whole process. In addition, multiple sequence alignments on a large number of 
proteins may produce a very complicated pattern of insertions and deletions, thus increasing the 
difficulty of analysis. In this paper, to improve the efficiency of identifying of the possible identical 
segments in a database, BLASTP was used and all sequences with E value less than 0.001 were  
pre-selected as the potential candidates. After this pre-selection step, PONDR-RIBS was applied for 
further analysis. 
Int. J. Mol. Sci. 2010, 11             
 
 
3742
 
4. Conclusions  
Two well-accepted bioinformatics tools, sequence alignment and disorder prediction, were 
combined to probe possible binding partners in protein databases. For MoRF regions [22,26], it is clear 
that such combination has many advantages in identifying the possible binding interactions. 
Furthermore, based on the rationalization of structural properties of disordered proteins, a method 
called reverse alignment was also proposed to identify the potential interactions between the reversely-
similar segment and the partners of the original fragment. 
In this paper, when applying BLAST to search similar segments in PDB and SwissProt, a small  
E-value of 0.0001 is applied. The results from small E-value have many advantages: a limited number 
of examples with high confidence; high efficiency in analyzing the biologically important functions of 
these example proteins; simplicity in explaining the rules of application. However, important examples 
may be overlooked. In this newly developed method, the general intrinsic disorder and the 
hydrophobic pattern are more important than the value of confidence. Actually, in the case of segment 
N of RNase E, increasing E-value from 0.0001 to 0.1 resulted in finding two additional possible 
binding partners. These additional possible partners also had sound conserved hydrophobic patterns 
and interesting disorder prediction. Further increase of the E-value to 1000 produced more than  
70 proteins. All these proteins had more than 50% sequence identity to the segment and partially kept 
the hydrophobic pattern. However, the increased E-value provided more candidates and increased the 
technical difficulty of analysis. Therefore, in this paper, the attention was focused at lower E-values 
and small amount of candidates.  
The comparison of species in Tables 1 and 2 is very interesting. In our study, the sequence of 
RNase E is from E.coli, while other three sequences (p53, SRC-3, and 4E-BP1) are all from human. As 
shown in Table 1, the N MoRF of RNase E has three matches, a fragment of hydroxyethylthiazole 
kinase (A5UA75), rRNA pseudouridylate synthase C (A4NVQ3), and CafA proteins (Q65S31). The 
first two proteins are from Haemophilus influenza, while the last one is from Mannheimia 
succiniciproducens. Although more solid evidence is required, the possibility of trans-species gene 
transfer and the functional conservation of transferred gene are very interesting. Furthermore, both 
proteins from Haemophilus influenza have two segments similar to the corresponding segments in 
RNase E of E. coli. Further analysis shows that there is a high level of sequence conservation between 
these two proteins. In comparison with hydroxyethylthiazole kinase, rRNA pseudouridylate synthase C 
has an extra C-terminal region. These two proteins may share the same reading frame.  
As indicated by the comparison of the interaction profiles of RNase E, A5UA75, and Q65S31 in 
STRING 8.2 [58], with high confidence these three proteins can interact with PNPase, Enolase, Protein 
hfq, and 60 kDa chaperonin. It is known that C3 and C4 MoRF region are responsible for the binding 
to Enolase and PNPase, respectively [29]. However, A5UA75 and Q65S31 do not have the segments 
similar to the C4 region of RNase E. Therefore, there is still a question about the existence of common 
regions of binding to PNPase among these three proteins. Besides this, the common regions interacting 
with Protein hfq and 60 kDa chaperonin are also unknown. This is also the indication that more 
deliberate techniques are required in future study. 
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The normal-order sequence alignment results in 12 possible candidates out of 21 for 13 segments of 
three proteins as in Table 1, while the reversely identified sequences in Table 2 are 10 out of 20. As 
indicated by these data, the combination of sequence alignment and disorder prediction may greatly 
narrow down the number of high-confidence interaction partners. Furthermore, the reverse alignment 
may discover new interaction partners as effective as the normal-order alignment. This is definitely 
important for our further understanding of protein-protein interaction networks. 
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